Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
Carregando...
Citações na Scopus
39
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
ADAMS, Paul
ALTES, Albert
BRISSOT, Pierre
BUTZECK, Barbara
CABANTCHIK, Ioav
CANCADO, Rodolfo
DISTANTE, Sonia
EVANS, Patricia
EVANS, Robert
GANZ, Tomas
Citação
HEPATOLOGY INTERNATIONAL, v.12, n.2, p.83-86, 2018
Resumo
Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p. Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.
Palavras-chave
Referências
- Bacon BR, 2011, HEPATOLOGY, V54, P328, DOI 10.1002/hep.24330
- Bardou-Jacquet E, 2015, J HEPATOL, V62, P682, DOI 10.1016/j.jhep.2014.10.025
- Brissot P, 2016, EXPERT REV GASTROENT, V10, P359, DOI 10.1586/17474124.2016.1119043
- De Buck E, 2012, J HEPATOL, V57, P1126, DOI 10.1016/j.jhep.2012.04.040
- Liu J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003150
- NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004
- Ong SY, 2017, LANCET HAEMATOL, V4, pE607, DOI 10.1016/S2352-3026(17)30214-4
- Pietrangelo A, 2010, J HEPATOL, V53, P3
- Vanclooster A, 2015, CLIN RES HEPATOL GAS, V39, P205, DOI 10.1016/j.clinre.2014.09.001